带状疱疹活疫苗预防带状疱疹后神经痛的长期有效性
BACKGROUND: Postherpetic neuralgia (PHN) occurs in 5-30% of individuals with herpes zoster (HZ) and is characterized by long-lasting pain. Zoster vaccine live (ZVL) is licensed for people 50 years and older to prevent HZ and PHN.…
要点
- 80岁及以上接种者与年轻接种者VE相似,免疫缺陷者与免疫正常者VE相似。
核心结论
- ZVL对PHN总体有效性约65%,对所有年龄组有效,并提供长达8年的中度保护。
主要发现
- 80岁及以上接种者VE与年轻接种者相似,免疫缺陷者VE与免疫正常者相似。
关键数值与推荐
- PHN定义为HZ发病后90至365天内的PHN诊断。
- VE估计采用Cox回归,按出生年份分层,调整性别、种族、流感疫苗接种、门诊就诊频率、合并症和免疫缺陷状态。
临床怎么用
- ZVL可为50岁及以上人群预防PHN提供约65%的保护,接种后第一年保护最强,并维持至第八年。
- 对80岁及以上及免疫缺陷者,ZVL仍可提供与年轻及免疫正常者相似的PHN保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postherpetic neuralgia (PHN) occurs in 5-30% of individuals with herpes zoster (HZ) and is characterized by long-lasting pain. Zoster vaccine live (ZVL) is licensed for people 50 years and older to prevent HZ and PHN. This study evaluated vaccine effectiveness (VE) of ZVL against PHN. METHODS: We conducted an open cohort study within Kaiser Permanente Northern California with continuous accrual of people as they became age-eligible for ZVL. We defined PHN using a PHN diagnosis between 90 and 365 days after an incident episode of HZ. We estimated VE against PHN using Cox regression with a calendar timeline stratified by year of birth and adjusted for sex, race, influenza vaccination, outpatient visit frequency, comorbidities, and immune compromise status. RESULTS: From 2007 to 2016, 1·5 million people entered the study population and 33% received ZVL. During 7·6 million person-years of follow-up, there were 62,205 HZ cases, 4150 (6·7%) of which went on to develop PHN. Overall VE for PHN was 64·8% (95% CI 61·3, 68). VE was 82·8% (95% CI 77·6, 86·7) during the first year after vaccination, 58·3% (95% CI 50.1, 65.2) during the third year, and then waned more gradually to 48·7% (95% CI 30·2, 62·3) during the eighth year. VE in persons vaccinated when aged 80 years or older was similar to VE in younger vaccinees. VE in persons vaccinated when immune compromised was similar to VE in immune competent. CONCLUSIONS: Overall, ZVL was 65% effective against PHN. It was effective in all age groups and provided moderate protection through 8 years.
引用
- Klein NP, Bartlett J, Fireman B, et al. Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention. Vaccine. 2019. PMID: 31301920. doi:10.1016/j.vaccine.2019.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。